Dambkowski Carl 4
4 · Apogee Therapeutics, Inc. · Filed Jul 16, 2026
Research Summary
AI-generated summary of this filing
Apogee Therapeutics CMO Carl Dambkowski Gifts 8,000 Shares
What Happened
- Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics (APGE), reported a gift of 8,000 company shares on July 14, 2026. The Form 4 shows the transaction as a gift (transaction code G) at $0.00 per share (total reported value $0).
Key Details
- Transaction date and price: 2026-07-14; gift reported at $0.00 per share.
- Shares transferred: 8,000 shares disposed (gift).
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- Footnote: F1 — the shares were gifted to a donor-advised fund (bona fide gift).
- Filing timeliness: Form 4 filed on 2026-07-16; this appears to be timely (filed within the typical two-business-day reporting window).
Context
- Gifts are a transfer of ownership and do not necessarily indicate the insider’s view of the company’s prospects; they can be for personal, tax, or charitable-planning reasons.
- For retail investors, purchases tend to be more informative about insider sentiment than gifts or routine transfers.
Insider Transaction Report
Form 4
Dambkowski Carl
Chief Medical Officer
Transactions
- Gift
Common Stock
[F1]2026-07-14−8,000→ 169,873 total
Footnotes (1)
- [F1]This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund.
Signature
/s/ Matthew Batters, as attorney-in-fact for Carl Dambkowski|2026-07-16